RhNRG-1β Protects the Myocardium against Irradiation-Induced Damage via the ErbB2-ERK-SIRT1 Signaling Pathway

PloS One
Anxin GuQingshan You

Abstract

Radiation-induced heart disease (RIHD), which is a serious side effect of the radiotherapy applied for various tumors due to the inevitable irradiation of the heart, cannot be treated effectively using current clinical therapies. Here, we demonstrated that rhNRG-1β, an epidermal growth factor (EGF)-like protein, protects myocardium tissue against irradiation-induced damage and preserves cardiac function. rhNRG-1β effectively ameliorated irradiation-induced myocardial nuclear damage in both cultured adult rat-derived cardiomyocytes and rat myocardium tissue via NRG/ErbB2 signaling. By activating ErbB2, rhNRG-1β maintained mitochondrial integrity, ATP production, respiratory chain function and the Krebs cycle status in irradiated cardiomyocytes. Moreover, the protection of irradiated cardiomyocytes and myocardium tissue by rhNRG-1β was at least partly mediated by the activation of the ErbB2-ERK-SIRT1 signaling pathway. Long-term observations further showed that rhNRG-1β administered in the peri-irradiation period exerts continuous protective effects on cardiac pump function, the myocardial energy metabolism, cardiomyocyte volume and interstitial fibrosis in the rats receiving radiation via NRG/ErbB2 signaling. Our findings indica...Continue Reading

References

Apr 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B W CornR L Goodman
Aug 5, 2005·Molecular Biology of the Cell·Eriko MichishitaIzumi Horikawa
May 16, 2006·The Journal of Biological Chemistry·Katrien LemmensGilles W De Keulenaer
Jul 11, 2006·Nature Reviews. Molecular Cell Biology·Ami Citri, Yosef Yarden
Nov 28, 2006·European Journal of Heart Failure·Katrien LemmensGilles W De Keulenaer
Jan 2, 2007·The Journal of Biological Chemistry·Masaya TannoYoshiyuki Horio
May 26, 2007·Science·Bijan SobhianRoger A Greenberg
Jan 19, 2008·Circulation Research·Jason Y ChanHideko Kasahara
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Young C KimGerhard Hummer
Oct 24, 2009·Molecular Cancer·Ana M CerveraKenneth J McCreath
Nov 10, 2009·Biochemical and Biophysical Research Communications·Kazutsune Yamagata, Issay Kitabayashi
Feb 18, 2010·International Journal of Radiation Oncology, Biology, Physics·Sarah C DarbyRoy E Shore
Dec 22, 2011·Nature Communications·Praphulla C ShuklaSubodh Verma
Mar 7, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Angela SardaroMaurizio Portaluri
Mar 20, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Brian Wadugu, Bernhard Kühn
Mar 31, 2012·Circulation Research·Ying Tian, Edward E Morrisey
Jul 17, 2012·Antioxidants & Redox Signaling·Sang-Bing OngDerek J Hausenloy
Jul 20, 2012·Physiological Reviews·Ruben NogueirasMatthias H Tschöp
Sep 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Ghazaleh GhobadiPeter van Luijk
Sep 19, 2012·Journal of Molecular and Cellular Cardiology·A PlanavilaF Villarroya
Nov 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Katrien ErvenCaroline Weltens
Dec 19, 2012·Journal of Cardiovascular Translational Research·Lorella PolidoroC Ferri
Mar 26, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Zarko BarjaktarovicSoile Tapio
Jan 1, 2014·International Journal of Cardiology·Konstantin SchwarzMichael P Frenneaux
Feb 27, 2014·Radiation Research·Vijayalakshmi SridharanMarjan Boerma
Apr 12, 2014·International Journal of Molecular Sciences·Jianguo LiFeiyue Fan
Apr 4, 2015·Science Translational Medicine·Brian D PolizzottiBernhard Kühn

❮ Previous
Next ❯

Citations

Mar 2, 2018·Expert Opinion on Pharmacotherapy·Nathalie DonisPatrizio Lancellotti
Jun 15, 2020·Journal of Cellular and Molecular Medicine·Bin WangXin Jiang
Mar 19, 2019·Oxidative Medicine and Cellular Longevity·Shashank ShrishrimalRebecca E Oberley-Deegan
Jul 28, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Qian WangPing Yang
Oct 25, 2016·The Journal of Clinical Investigation·Akshay ShekharDavid S Park
Oct 12, 2020·Current Cardiology Reports·Samantha XuMilind Y Desai
Feb 17, 2021·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Márta SárközyTamás Csont

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
protein assay
Electrophoresis
fluorescence microscopy
X-ray
xenograft

Software Mentioned

Image Pro Plus
Excel
Adobe Photoshop
GraphPad Prism

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.